Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10039005HBVENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TVIS10043870HBVENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TVIS20053528HPVENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TVIS44004415HTLV-1ENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TVIS44047840HTLV-1ENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TVIS44047839HTLV-1ENSG00000141401.12protein_codingIMPA2NoNo3613O14732
TCGA Plot Options
Drug Information
GeneIMPA2
DrugBank IDDB14508
Drug NameLithium succinate
Target IDBE0000983
UniProt IDO14732
Regulation Type
PubMed IDs16841073; 17068342; 17251911
CitationsCryns K, Shamir A, Shapiro J, Daneels G, Goris I, Van Craenendonck H, Straetemans R, Belmaker RH, Agam G, Moechars D, Steckler T: Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology. 2007 Apr;32(4):881-91. Epub 2006 Jul 12.@@Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T: Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. J Biol Chem. 2007 Jan 5;282(1):637-46. Epub 2006 Oct 26.@@Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, Hattori E, Inada T, Kunugi H, Tatsumi M, Ozaki N, Iwata N, Sakamoto K, Iijima Y, Iwata Y, Tsuchiya KJ, Sugihara G, Nanko S, Osumi N, Detera-Wadleigh SD, Kato T, Yoshikawa T: A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology. 2007 Aug;32(8):1727-37. Epub 2007 Jan 24.
GroupsExperimental
Direct ClassificationDicarboxylic acids and derivatives
SMILES[Li+].[Li+].[O-]C(=O)CCC([O-])=O
Pathways
PharmGKB
ChEMBLCHEMBL3707288